Doctor profile · Federal record

Dr. Frank Scott, D.O.

Rheumatology Physician (CMS: Rheumatology) · Nipomo, CA

  • NPI 1295877207
  • Accepts Medicare
  • MIPS 64.6 / 100 · 2023
  • 51 yrs in practice
  • Male
  • Solo practice
  • No sanctions

Practice & contact

Operates at 3 locations .

NPPES Updated May 11, 2026
Primary practice
671 W Tefft St Ste 13
Nipomo, CA 934448988
(805) 473-4001
fax (805) 477-3925
Additional location
5315 W Hillsdale Ave
Visalia, CA 932915118
(559) 732-9900
fax (559) 732-9908
Additional location
6327 N Fresno St Ste 101
Fresno, CA 937105236
(559) 732-9900
fax (559) 732-9909

Credentials & registration

NPPES · NUCC
NPI registered
February 2007 — 19 yrs on file
Profile last updated
February 24, 2025
Year of graduation
1975 — 51 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
California #20A7253

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1295877207. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
11,119
Distinct HCPCS
10
Medicare allowed
$332,602
HCPCS Description Services Patients Avg allowed
J1306 Injection, inclisiran, 1 mg 5,964 12 $12
J0897 Injection, denosumab, 1 mg 3,420 31 $23
99214 Established patient office or other outpatient visit, 30-39 minutes 832 426 $127
99213 Established patient office or other outpatient visit, 20-29 minutes 203 147 $91
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 122 35 $79
96413 Administration of chemotherapy into vein, 1 hour or less 114 24 $142
99204 New patient office or other outpatient visit, 45-59 minutes 106 106 $169
96372 Injection of drug or substance under skin or into muscle 85 64 $15
J1040 Injection, methylprednisolone acetate, 80 mg 74 59 $11
J1885 Injection, ketorolac tromethamine, per 15 mg 64 15 $1

In context: peer comparison

Among 1 peers in this city , average services per provider: 741. This provider delivers 15× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,897
Transactions
135
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
ABBVIE INC. 47 $1,099.47
Amgen Inc. 28 $466.40
Novartis Pharmaceuticals Corporation 21 $367.78
Janssen Biotech, Inc. 12 $281.66
Aurinia Pharma U.S., Inc. 7 $160.32
AstraZeneca Pharmaceuticals LP 6 $131.96
PFIZER INC. 5 $106.28
GENZYME CORPORATION 2 $97.53
Teva Pharmaceuticals USA, Inc. 1 $29.73
Octapharma USA, Inc. 1 $25.83
Almatica Pharma LLC 1 $23.74
Organon Llc 1 $22.84
Fresenius Kabi USA, LLC 1 $22.30
E.R. Squibb & Sons, L.L.C. 1 $21.79
SOBI, INC 1 $21.06

By nature of payment

Food and Beverage
$2,871
Education
$26

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
970
Patients
132
Total drug cost
$2,268,676
Drug Type Claims Patients Total cost
Methotrexate (Methotrexate Sodium) Brand 186 37 $7,275
Prednisone Generic 181 41 $1,415
Enbrel Sureclick (Etanercept) Brand 108 16 $794,036
Humira(Cf) Pen (Adalimumab) Brand 88 11 $632,609
Hydroxychloroquine Sulfate Generic 64 14 $5,207
Mycophenolate Mofetil Generic 59 0 $7,858
Alendronate Sodium Generic 48 13 $425
Meloxicam Generic 38 0 $127
Rinvoq (Upadacitinib) Brand 38 0 $246,428
Xeljanz Xr (Tofacitinib Citrate) Brand 34 0 $249,851

Frequently asked questions

Auto-generated from federal data
What is Dr. Frank Scott's medical specialty?
Dr. Frank Scott practices Rheumatology Physician in Nipomo, CA.
Where does Dr. Frank Scott practice?
Dr. Frank Scott practices at 671 W Tefft St Ste 13, Nipomo, CA 934448988. Office phone: 8054734001.
What is Dr. Frank Scott's NPI?
Dr. Frank Scott's National Provider Identifier (NPI) is 1295877207, issued by NPPES.
Does Dr. Frank Scott accept Medicare assignment?
Yes. Dr. Frank Scott accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Frank Scott commonly perform?
Top Medicare-reported procedures in 2023: Injection, inclisiran, 1 mg (HCPCS J1306); Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.